We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETON icon
526
Eton Pharmaceutcials
ETON
$1.19B
$14.7K ﹤0.01%
597
+70
+13% +$1.22K
CSR
527
Centerspace
CSR
$939M
$14.7K ﹤0.01%
255
-24
-9% -$1.51K
ESPR
528
DELISTED
Esperion Therapeutics
ESPR
$14.6K ﹤0.01%
5,345
+649
+14% +$2.06K
SMA
529
SmartStop Self Storage REIT
SMA
$1.9B
$14.4K ﹤0.01%
476
-38
-7% -$1.22K
PRME icon
530
Prime Medicine
PRME
$564M
$14K ﹤0.01%
4,036
+489
+14% +$1.86K
DEA
531
Easterly Government Properties
DEA
$1.17B
$14K ﹤0.01%
654
-53
-7% -$1.21K
BIOA
532
BioAge Labs
BIOA
$1B
$13.9K ﹤0.01%
797
+93
+13% +$1.79K
JBGS
533
JBG SMITH
JBGS
$839M
$13.8K ﹤0.01%
947
-76
-7% -$1.21K
AAT
534
American Assets Trust
AAT
$1.55B
$13.6K ﹤0.01%
741
-60
-7% -$1.12K
DSGN icon
535
Design Therapeutics
DSGN
$745M
$13.5K ﹤0.01%
1,271
+153
+14% +$1.55K
REPL icon
536
Replimune Group
REPL
$917M
$13.4K ﹤0.01%
1,752
+212
+14% +$1.62K
TECX
537
Tectonic Therapeutic
TECX
$615M
$12.8K ﹤0.01%
415
+48
+13% +$1.18K
IRWD icon
538
Ironwood Pharmaceuticals
IRWD
$634M
$12.8K ﹤0.01%
3,636
+440
+14% +$1.8K
PSNL icon
539
Personalis
PSNL
$1.43B
$12.6K ﹤0.01%
1,982
+238
+14% +$2.01K
SLDB icon
540
Solid Biosciences
SLDB
$836M
$12.5K ﹤0.01%
1,739
+209
+14% +$1.34K
PDM
541
Piedmont Realty Trust
PDM
$1.21B
$12.5K ﹤0.01%
1,898
-158
-8% -$1.23K
ALLO icon
542
Allogene Therapeutics
ALLO
$628M
$12.3K ﹤0.01%
5,047
+769
+18% +$1.54K
CRMD icon
543
CorMedix
CRMD
$621M
$11.9K ﹤0.01%
1,760
+212
+14% +$1.57K
ASTS icon
544
AST SpaceMobile
ASTS
$19.1B
$11.9K ﹤0.01%
144
-462
-76% -$43.6K
FDMT icon
545
4D Molecular Therapeutics
FDMT
$612M
$11.9K ﹤0.01%
1,275
+153
+14% +$1.33K
ZVRA icon
546
Zevra Therapeutics
ZVRA
$732M
$11.7K ﹤0.01%
1,256
+150
+14% +$1.35K
PRTA icon
547
Prothena Corp
PRTA
$450M
$11.7K ﹤0.01%
1,199
+142
+13% +$1.3K
CMPS
548
Compass Pathways
CMPS
$1.62B
$11.6K ﹤0.01%
2,104
+253
+14% +$1.7K
ESRT icon
549
Empire State Realty Trust
ESRT
$957M
$11.4K ﹤0.01%
2,192
-183
-8% -$1.1K
WSR
550
DELISTED
Whitestone REIT
WSR
$11.4K ﹤0.01%
704
-57
-7% -$858
20 21
22
23 24

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.